Verition Fund Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-61,553
| Closed | -$299K | – | 2933 |
|
|
2025
Q1 | $299K | Buy |
61,553
+38,022
| +162% | +$185K | ﹤0.01% | 2229 |
|
|
2024
Q4 | $225K | Buy |
+23,531
| New | +$225K | ﹤0.01% | 2275 |
|
|
2024
Q3 | – | Sell |
-29,544
| Closed | -$201K | – | 2545 |
|
|
2024
Q2 | $201K | Buy |
+29,544
| New | +$201K | ﹤0.01% | 1952 |
|
|
2023
Q4 | – | Sell |
-70,274
| Closed | -$239K | – | 1967 |
|
|
2023
Q3 | $239K | Buy |
70,274
+54,916
| +358% | +$187K | ﹤0.01% | 1541 |
|
|
2023
Q2 | $113K | Buy |
+15,358
| New | +$113K | ﹤0.01% | 1680 |
|